Zhejiang Gongdong Medical Technology Co Ltd - Asset Resilience Ratio
Zhejiang Gongdong Medical Technology Co Ltd (605369) has an Asset Resilience Ratio of 4.36% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read 605369 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2020–2024)
This chart shows how Zhejiang Gongdong Medical Technology Co Ltd's Asset Resilience Ratio has changed over time. See 605369 total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Gongdong Medical Technology Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Zhejiang Gongdong Medical Technology Co .
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥92.82 Million | 4.36% |
| Total Liquid Assets | CN¥92.82 Million | 4.36% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Gongdong Medical Technology Co Ltd maintains only 4.36% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Gongdong Medical Technology Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Gongdong Medical Technology Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Alcon AG
SW:ALC |
Medical Instruments & Supplies | 0.26% |
|
iRay Technology Co Ltd
SHG:688301 |
Medical Instruments & Supplies | 0.68% |
|
Anbio Biotechnology Class A Ordinary Shares
NASDAQ:NNNN |
Medical Instruments & Supplies | 29.19% |
|
Jiangsu Nanfang Medical
SHG:603880 |
Medical Instruments & Supplies | 2.27% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 6.36% |
|
I.Ceram SA
PA:ALICR |
Medical Instruments & Supplies | -1.61% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 4.42% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 51.82% |
Annual Asset Resilience Ratio for Zhejiang Gongdong Medical Technology Co Ltd (2020–2024)
The table below shows the annual Asset Resilience Ratio data for Zhejiang Gongdong Medical Technology Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 7.20% | CN¥140.47 Million ≈ $20.55 Million |
CN¥1.95 Billion ≈ $285.54 Million |
+1.87pp |
| 2021-12-31 | 5.33% | CN¥90.00 Million ≈ $13.17 Million |
CN¥1.69 Billion ≈ $247.29 Million |
+2.39pp |
| 2020-12-31 | 2.93% | CN¥40.35 Million ≈ $5.90 Million |
CN¥1.38 Billion ≈ $201.30 Million |
-- |
About Zhejiang Gongdong Medical Technology Co Ltd
Zhejiang Gongdong Medical Technology Co., Ltd. researches, develops, produces, and sells disposable medical consumables in China. Its products include blood collection tubes, needles and needle holders, and sharp containers; cell culture dishes, plates, bottles, flasks, and serological pipette solutions; laboratory consumables, such as petri dishes, centrifuge and cryo tubes, pipette tips, transf… Read more